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Abstract 
 
Background. Coronavirus disease 2019 (COVID-19) epidemics strain health systems and 
households. Health systems in Africa and South Asia may be particularly at risk due to 
potential high prevalence of risk factors for severe disease, large household sizes and limited 
healthcare capacity. 
 
Methods. We investigated the impact of an unmitigated COVID-19 epidemic on health 
system resources and costs, and household costs, in Karachi, Delhi, Nairobi, Addis Ababa 
and Johannesburg. We adapted a dynamic model of SARS-CoV-2 transmission and disease to 
capture country-specific demography and contact patterns. The epidemiological model was 
then integrated into an economic framework that captured city-specific health systems and 
household resource use. 
 
Findings. The cities severely lack intensive care beds, healthcare workers and financial 
resources to meet demand during an unmitigated COVID-19 epidemic. A highly mitigated 
COVID-19 epidemic, under optimistic assumptions, may avoid overwhelming hospital bed 
capacity in some cities, but not critical care capacity.  
 
Interpretation. Viable mitigation strategies encompassing a mix of responses need to be 
established to expand healthcare capacity, reduce peak demand for healthcare resources, 
minimise progression to critical care and shield those at greatest risk of severe disease. 
 
Funding. Bill & Melinda Gates Foundation, European Commission, National Institute for 
Health Research, Department for International Development, Wellcome Trust, Royal 
Society, Research Councils UK. 
 
Key words 
Coronavirus disease 2019 (COVID-19); health systems; intensive care; low- and middle-
income countries  
 . CC-BY 4.0 International licenseIt is made available under a 
 is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)
The copyright holder for this preprint this version posted May 8, 2020. .https://doi.org/10.1101/2020.05.06.20092734doi: medRxiv preprint 
Research in context 
 
Evidence before this study 
 
We conducted a PubMed search on May 5, 2020, with no language restrictions, for studies 
published since inception, combining the terms (“cost” OR “economic”) AND “covid”. Our 
search yielded 331 articles, only two of which reported estimates of health system costs of 
COVID-19. The first study estimated resource use and medical costs for COVID-19 in the 
United States using a static model of COVID 19. The second study estimated the costs of 
polymerase chain reaction tests in the United States. We found no studies examining the 
economic implications of COVID-19 in low- or middle-income settings. 
 
Added value of this study 
 
This is the first study to use locally collected data in five cities (Karachi, Delhi, Nairobi, Addis 
Ababa and Johannesburg) to project the healthcare resource and health economic 
implications of an unmitigated COVID-19 epidemic. Besides the use of local data, our study 
moves beyond existing work to (i) consider the capacity of health systems in key cities to 
cope with this demand, (ii) consider healthcare staff resources needed, since these fall short 
of demand by greater margins than hospital beds, and (iii) consider economic costs to health 
services and households.  
 
Implications of all the evidence 
 
Demand for ICU beds and healthcare workers will exceed current capacity by orders of 
magnitude, but the capacity gap for general hospital beds is narrower. With optimistic 
assumptions about disease severity, the gap between demand and capacity for general 
hospital beds can be closed in some, but not all the cities. Efforts to bridge the economic 
burden of disease to households are needed. 
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Introduction 
 
Coronavirus disease 2019 (COVID-19) is an acute respiratory illness caused by severe acute 
respiratory syndrome coronavirus 2 (SARS-CoV-2). It emerged in China in late 2019 and 
spread rapidly before being declared a pandemic by the World Health Organization on 11 
March 2020. The first reported cases in South Asia and Africa occurred, respectively, in 
Nepal on 24 January 2020 and Egypt on 14 February 2020. As of 4 May 2020, cases have 
been reported in all countries in both regions except for Lesotho1. 
 
Mathematical models have projected the likely health burden of a COVID-19 epidemic in 
many parts of the world2–4. These models suggest that an unmitigated epidemic will almost 
certainly exceed the healthcare capacity of any country. For example, an unmitigated 
COVID-19 epidemic in the United Kingdom is projected to peak within 11 weeks of the first 
case and eventually infect 85% of the population, with about 17% of cases occurring in a 
single week5. Some of these infections require hospital treatment (including supplemental 
oxygen) and a smaller proportion require critical care (with most critical cases requiring 
mechanical ventilation). Both proportions rise steeply with age and the presence of chronic 
medical conditions6. In the absence of vaccines or effective therapies to reduce the peak 
incidence of severe COVID-19 outcomes, many countries have resorted to non-
pharmaceutical interventions such as travel restrictions and physical distancing measures to 
delay the spread of SARS-CoV-2, reduce peak incidence and hence avoid overwhelming 
health systems resources.  
 
However, the potential benefit of such interventions has been questioned in settings 
beyond North America, Europe and East Asia. Mitigation measures, such as restrictions on 
economic and educational activities, can have a larger detrimental effect on national and 
household economies in Africa and South Asia compared to high-income countries. In Africa 
and South Asia, households are less able to absorb financial shocks due to lower levels of 
household savings, while governments may not be able to fund compensatory schemes for 
people losing income due to lack of fiscal surpluses and access to affordable debt. Health 
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system resources are more constrained due to lack of funding. The severity of a COVID-19 
epidemic may be exacerbated in these settings by high prevalence of HIV and tuberculosis, 
poor living conditions, large household sizes and limited hospital capacity, although this may 
be mitigated by a younger population and lower prevalence of some comorbidities7 
compared to high-income settings. Hence patterns of healthcare demand are likely to differ 
from high-income settings, but even a highly mitigated epidemic may exceed healthcare 
capacity. Projections of the health systems implications of COVID-19 epidemics in such 
settings are vital for health systems preparedness and choice of mitigation measures. 
 
To date, no study has looked at the COVID-19-related health resource demand and capacity 
in Africa and South Asia. To address this gap, we used a combined epidemiological-health 
systems model to understand the spread of SARS-CoV-2 and its impact on hospital and 
critical care beds, healthcare worker time and costs in Karachi, Delhi, Nairobi, Addis Ababa 
and Johannesburg. These five megacities were chosen to be all in resource constrained 
settings, but vary in terms of population demography, healthcare capacity, income 
distribution and quality of healthcare data. 
 
Methods 
 
Infection transmission and natural history 
 
We adapted a previously-described5 age-structured stochastic compartmental mathematical 
model of SARS-CoV-2 transmission (see Figure S1.1 for model flow diagram, and Table S1.1-
1.2 for model parameters with references). The population is stratified into 5-year age 
groups from 0-4 years to 70-74 years, and one age group for 75+ years. The total population 
size and its age distribution for 2020 are retrieved from WorldPop8. 
 
Mixing between individuals is age-stratified, with the age-specific contact rates for each city 
adopted from synthetic contact matrices constructed for 152 countries9. The entire 
population starts susceptible. To initiate the epidemic, we assume that one infectious 
person enters the population at time 0. We run 100 simulations for each city, drawing a 
different value for R0 for each simulation. Upon contact with an infectious person, a 
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susceptible individual enters the exposed state with a probability depending on the 
susceptibility of that individual. The susceptibility is determined by the value of R0, assumed 
for a given simulation of the model. We assume that R0 is drawn from a normal distribution 
with mean 2.68 and standard deviation 0.57, in keeping with values for R0 measured in 
settings with no substantial control measures in place5.  
 
After spending time in that state, individuals enter either a clinically or subclinically infected 
state. Clinically infected individuals are those who eventually show clinical symptoms, while 
subclinically infected individuals are those who show mild symptoms or no symptoms (the 
latter sometimes referred to as “asymptomatic” individuals). The probability of showing 
clinical symptoms is age-dependent and estimated from case data from China, Japan, 
Singapore, South Korea, Italy, and Canada10. Individuals in the preclinical state enter the 
clinical state after several days, and then the removed state. Individuals in the subclinical 
state enter the removed state directly. The removed state represents all those who have 
recovered, died, or have been isolated from the community, and hence are no longer 
infectious. We assume that preclinical infections are as infectious as clinical infections, while 
subclinical infections are    0.5 times as infectious as clinical infections, consistent with 
empirical measurements showing reduced infectiousness of asymptomatic SARS-CoV-2 
infections10–12. 
 
Disease severity 
 
There are no published data about the risk of hospitalisation, ICU admission or death 
following COVID-19 infection in Africa or South Asia. Hence for our base case scenario, we 
used risks based on our previous work using data from China5, which are similar to data 
from the USA13 and Italy14 (see Table S2). 
 
However, our admissions data assume that countries strictly follow WHO best practice 
guidelines for clinical management. In the presence of an extreme surge in healthcare 
demand, we expect that countries will go into “surge” mode by reducing the proportion of 
patients who are triaged to admission, and discharging them as soon as possible. Hence we 
also examined a hypothetical scenario where both patient admission rates and length of 
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stay were decreased by 50% (i.e. 7.3 days in the general ward for severe cases; 3 days in the 
general ward followed by 4.8 days in ICU for critical cases). 
 
Another complication is that the prevalence of underlying clinical conditions associated with 
more severe COVID-19 disease (such as chronic kidney disease, chronic heart disease and 
diabetes) is about half as prevalent in Africa compared to Europe7, so severity may actually 
be lower in the settings we examine. On the other hand, the prevalence of HIV, TB and 
malnutrition combined are about an order of magnitude greater7, and life expectancy in 
Africa is less than Europe even after adjusting for greater childhood mortality. Hence 
severity may be greater in these settings. To take into account both possibilities, we varied 
the odds of hospitalisation (given being a case) and death (given hospitalisation) from 50% 
to 150% of the base case scenario. 
 
Health systems and household resources 
 
We estimate the impact of COVID-19 on health system resources and costs incurred by 
health systems and households. Full details of data, modelling and references used to 
estimate resources and costs are in Supplemental Material S2 
 
Impact includes basic emergency response management and communication, case 
reporting, diagnosis and clinical management. These estimates represent an ideal scenario, 
with services provided according to international guidelines15,16, but account for the real 
costs of providing these services currently in each setting. Hence, we also provide the 
“surge” scenario above to describe how healthcare systems in these settings may react 
when faced with overwhelming demand. The costing model assumes no economies of scale 
at the site level. 
 
For above-service costs, such as training in case management and case reporting, quantities 
of staff and building/equipment per day were estimated. Service-level costs for diagnosis 
and clinical management services were estimated using a bottom-up ingredients approach. 
Unit costs of outputs, such as bed-days and outpatient visits were sourced from a range of 
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primary published and unpublished data, representing the best available estimates of unit 
costs in each country.  
 
Unit cost estimates represent the economic cost of all resources required to produce health 
services, including staff time, capital and equipment, drugs, supplies, and overhead costs.  
These unit costs were combined with normative guidelines and published evidence on 
quantities of health services required for COVID-19 cases. For all clinical management 
services, the quantity of bed-days per COVID symptomatic case were defined using available 
literature on length of stay for severe and critical COVID-19 cases. The number of visits, 
regiments, supplies, and tests for diagnosis and clinical management services were defined 
using standard case management guidelines from the WHO15 and United Kingdom16. Costs 
of critical case management also included the costs of co-morbidities and complications, the 
frequency of which were estimated using evidence from China. Additional resources were 
added to account for costs specific to COVID-19 treatment and infection control, including 
mechanical ventilation of patients and personal protective equipment for health care 
workers. Quantities of ventilation and PPE were sourced from WHO standard case 
management guidelines. We also include a cost of managing death, assuming one body bag 
per COVID-related death.  
 
We compare resource use against three different capacity constraints: ICU bed-days, 
general bed-days and health care workers, sourced from WHO global databases and 
country-specific data sources. Where city specific data were not available, we assume that 
cities have twice the national average number of hospital beds per capita. 
 
We estimate household costs of illness using an adaptation of a previously published model 
on the costs of illness associated with symptoms of tuberculosis (persistent cough and fever) 
from South Africa17. We adjusted the model to reflect COVID-19 age distribution based on 
outputs of the epidemiological model, and used the best-available estimates of household-
incurred costs per hospital bed-day for each country. Costs to households included direct 
medical (ie. user charges, prescription fees) and non-medical (ie. transport, accommodation) 
out-of-pocket payments, as well as lost income due to sickness. Cases in hospital were also 
assumed to incur productivity costs for the duration of hospitalization for one caregiver. We 
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also include a household cost of death, consisting of funeral costs and one year of lost 
income if the deceased was an income-earner. All costs were converted and inflated to 2019 
US dollars using GDP deflators and exchange rates from the World Bank. Where prices were 
adjusted across settings, we used GDP at purchasing power parity (PPP) for non-tradable 
goods. 
  
Results 
 
Cases and deaths 
 
Figure 1 (top row) shows the projected number of cases and deaths due to COVID-19 over 
the course of an unmitigated epidemic in each city. Supplemental material S3 shows 
numbers that are projected to occur over time. In each city, cases are predicted to peak 
around the same time (median 103-119 days after introduction of the first case, depending 
on city) in an unmitigated epidemic, with hospital and ICU bed demand peaking soon after 
that (median 111-129 days and 115-132 days respectively). The peak may be reached 
sooner than three months after the first detected case if surveillance systems are not 
sensitive enough to pick up the first few sporadic cases. 
 
Health systems resources 
 
Figure 1 (bottom row) shows the number of general hospital beds and ICU beds needed due 
to COVID-19 over the course of an unmitigated epidemic in each city. Supplemental material 
S3 shows how the number of general hospital beds, ICU beds and health care workers 
needed to deal with COVID-19 will change over the course of the epidemic. Peak demand is 
shown in Figure 4. 
 
The greatest capacity gap is in ICU beds, where median demand in all five cities is expected 
to exceed bed capacity by 25 (Johannesberg) – 5400 (Addis Ababa) times. The capacity gap 
for health care staff is also large: 13 (Johannesburg) – 56 (Addis Ababa) times. For hospital 
capacity, the shortfall is the smallest, with the gap ranging from 3.9 (Nairobi) – 19 (Addis 
Ababa) times. 
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Economic costs 
 
Figure 2 shows the economic costs that are incurred due to COVID-19 by both the 
healthcare system and households; the costs over time are shown in Figure 3. Median total 
costs are $43, $56, $66, $33 and $248 per person in Karachi, Delhi, Nairobi, Addis Ababa and 
Johannesburg respectively. The categories with the highest costs are income losses incurred 
by households due to patients and their caregivers being unable to work. In comparison, 
current total/domestic health expenditure per capita are $40/$11 in Pakistan, $62/$16 in 
India, $66/$24 in Kenya, $27/$8 in Ethiopia and $428/$230 in South Africa18. 
 
Alternative scenarios 
 
Figure 4 shows how peak hospital bed, ICU bed and healthcare worker demand may change 
if different assumptions about severity and demand per patient are made. Peak demand for 
ICU beds and healthcare workers remains many times greater than capacity under all 
scenarios. For general hospital beds, under the most optimistic scenarios, capacity is almost 
able to meet peak demand in the three African cities. 
 
Discussion 
 
Using a model that integrates epidemiological, health systems and health economic 
outcomes, we projected the health service and economic resources needed during an 
unmitigated COVID-19 epidemic in five cities in Africa and South Asia. We find that demand 
for ICU beds and healthcare workers will exceed current capacity by orders of magnitude, 
but the capacity gap for general hospital beds is narrower. Costs falling on both the 
healthcare sector and on households will also be large, and be close to normal annual 
healthcare expenditure due to all causes in all the cities except Johannesburg. 
 
With optimistic assumptions about disease severity, the gap between demand and capacity 
for general hospital beds is closer in some, but not all the cities. If lengths of stay can be 
reduced and existing beds can be made available for COVID-19 patients, the gap may be 
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small enough to be bridged by a combination of different mitigation measures that flatten 
the epidemic curve (and hence reduce peak demand for beds). The impact of such 
interventions on health outcomes in resource-constrained settings has been explored 
elsewhere19. Effective measures include physical distancing, shielding of vulnerable patients 
(such as older adults with comorbidities) most likely to require hospital admission and 
construction of field hospitals. Conversely, the shortfall in critical care capacity is likely too 
large to bridge within the available to prepare for the epidemic peak (and possibly even 
future waves). 
 
Our modelling takes into account the demographic age profile of the different cities. Hence 
Nairobi and Addis Ababa are projected to have less severe health care demand shocks 
compared to the older populations in Johannesburg, Delhi and Karachi more susceptible to 
severe disease. However, all these cities contain large floating populations such as migrant, 
informal and casual workers who are not fully in census or even satellite imagery data used 
by WorldPop to construct city populations8. These populations may also bear the brunt of 
the economic cost of physical distancing and other epidemic mitigation measures. For 
instance, the lockdown in India (since March 25, extended to May 3) has caused a significant 
economic shock to millions of migrant and daily wage workers in the informal sector20. 
Hence extremely difficult decisions are needed to trade off the costs of an unmitigated 
epidemic that we present with the costs of mitigation measures, with both costs falling on 
both healthcare systems and households.  
 
Several studies have projected the number of cases, hospital admissions and ICU admissions 
that a COVID-19 epidemic would cause in countries around the world, including Africa and 
South Asia34. Our findings move beyond these studies by (i) considering also the capacity of 
health systems in key cities to cope with this demand, (ii) considering the healthcare staff 
resources needed, since these fall short of demand by greater margins than hospital beds, 
and (iii) considering economic costs to health services and households. These costs include a 
variety of resources, and hence highlight the inadequacy of simply providing beds, oxygen 
tanks or ventilators without supporting equipment and staff. For example, costs associated 
with treatment of severe pneumonia include high-flow oxygen, pulse oximeters and health 
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care staff with training in respiratory medicine in order to effectively recognise and manage 
hypoxemic COVID-19 patients before they reach a critical condition. 
 
There are a number of important caveats to our findings. The first is that we are examining 
health care worker capacity considering only doctors, nursing and midwifery staff who are 
currently available. We do not consider the possibility that staff with less formal training 
might receive on-the-job training to manage COVID-19 patients. However, we also do not 
consider that health care workers may themselves be unavailable due to COVID-19 or 
responsibilities to family members with COVID-19, as has been reported in many countries 
facing COVID-19 epidemics21. Second, our capacity figures show resources available for all 
healthcare needs, but not all of these can be allocated to COVID-19 patients even if elective 
procedures are postponed for as long as possible. Indeed, most hospital beds in these cities 
are near full occupancy, and many health care workers work outside the hospitals. Further 
work needs to be done to further examine and understand real capacity constraints and the 
opportunity costs of transferring capacity to COVID-19, where the proportion of hospital 
admissions that are acute may be higher in high- income settings. Third, our cost results 
suggest that substantial additional financing is required. However, even where financing 
may be made available, we do not account for the absorption capacity to use this financing 
quickly to purchase commodities, construct new infrastructure, train new staff and institute 
substantial service delivery changes, which will challenge many LMICs, as it has done in high-
income countries. Lastly, our economic costs assume that all symptomatic cases would be 
isolated for the full 7 days recommended by WHO. In practice, this recommendation may 
not be adhered to by patients with mild disease. Similarly, not all households will necessarily 
lose income while ill, since some ill individuals may continue to work.  
 
Conclusion 
 
The consequences of addressing an unmitigated epidemic are substantial for both health 
sectors and households, risking considerable long-term damage to the economic well-being 
of both. Addressing COVID-19 in LMICs requires a nuanced and comprehensive approach, 
which fully considers capacity strengths and constraints in each setting; and trade-offs with 
broader considerations around poverty alleviation.  
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Figure 1. Total projected number of cases, deaths, hospital bed days and ICU bed days over 
the course of the unmitigated epidemic. 
 
Figure 2. Economic costs per person in the population due to COVID-19 falling on the health 
system (planning, response, distancing, testing and treatment) and on households 
(mortality, out-of-pocket, income loss). Error bars show 95% uncertainty range. 
 
Figure 3. Total economic costs due to COVID-19 by cost category incurred over time. 
 
Figure 4. Peak demand for hospital beds, ICU beds and healthcare workers compared to 
capacity, given different assumptions about severity compared to higher-income settings 
and bed occupancy (surge assumptions or not).  Error bars show 95% uncertainty range. 
Discussion 
  
 . CC-BY 4.0 International licenseIt is made available under a 
 is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)
The copyright holder for this preprint this version posted May 8, 2020. .https://doi.org/10.1101/2020.05.06.20092734doi: medRxiv preprint 
References 
 
1 World Health Organization. Coronavirusdisease (COVID-19) Situation Report–105. 
2020. https://www.who.int/docs/default-source/coronaviruse/situation-
reports/20200504-covid-19-sitrep-105.pdf?sfvrsn=4cdda8af_2 (accessed May 4, 
2020). 
2 Pearson CAB, Zandvoort K van, Jarvis CI, et al. Projections of COVID-19 epidemics in 
LMIC countries. 2020. https://cmmid.github.io/topics/covid19/LMIC-projection-
reports.html (accessed May 4, 2020). 
3 Walker P, Whittaker C, Watson O, et al. Report 12: The global impact of COVID-19 and 
strategies for mitigation and suppression. 2020. 
https://spiral.imperial.ac.uk:8443/handle/10044/1/77735 (accessed May 4, 2020). 
4 Institute for Health Metrics and Evaluation. COVID-19 Projections. 2020. 
https://covid19.healthdata.org/ (accessed May 4, 2020). 
5 Davies NG, Kucharski AJ, Eggo RM, Gimma A, Group CC-19 W, Edmunds WJ. The 
effect of non-pharmaceutical interventions on COVID-19 cases, deaths and demand 
for hospital services in the UK: a modelling study. medRxiv 2020; : 
2020.04.01.20049908. 
6 Verity R, Okell LC, Dorigatti I, et al. Estimates of the severity of coronavirus disease 
2019: a model-based analysis. Lancet Infect Dis 2020; 0. DOI:10.1016/S1473-
3099(20)30243-7. 
7 Clark A, Jit M, Warren-Gash C, et al. How many are at increased risk of severe COVID-
19 disease? Rapid global, regional and national estimates for 2020. medRxiv 2020; : 
2020.04.18.20064774. 
8 WorldPop, Center for International Earth Science Information Network (CIESIN). 
Global High Resolution Population Denominators Project. 2020. 
https://www.portal.worldpop.org/demographics/ (accessed May 4, 2020). 
9 Prem K, Cook AR, Jit M. Projecting social contact matrices in 152 countries using 
contact surveys and demographic data. PLoS Comput Biol 2017; 13. 
DOI:10.1371/journal.pcbi.1005697. 
10 Davies NG, Klepac P, Liu Y, et al. Age-dependent effects in the transmission and 
control of COVID-19 epidemics. 2020. 
https://cmmid.github.io/topics/covid19/age_hypotheses.html (accessed May 4, 
2020). 
11 Yi C, Aihong W, Bo Y, et al. The epidemiological characteristics of infection in close 
contacts of COVID-19 in Ningbo city. Chinese J Epidemiol 2020; 41: E026–E026. 
12 Luo L, Liu D, Liao X, et al. Modes of contact and risk of transmission in COVID-19 
among close contacts. medRxiv 2020; : 2020.03.24.20042606. 
13 Bialek S, Boundy E, Bowen V, et al. Severe Outcomes Among Patients with 
Coronavirus Disease 2019 (COVID-19) — United States, February 12–March 16, 2020. 
MMWR Morb Mortal Wkly Rep 2020; 69: 343–6. 
14 Riccardo F, Ajelli M, Andrianou X, et al. Epidemiological characteristics of COVID-19 
cases in Italy and estimates of the reproductive numbers one month into the 
epidemic. medRxiv 2020; : 2020.04.08.20056861. 
15 Organization WH. Critical preparedness, readiness and response actions for COVID-
19. 2020. 
16 BMJ. BMJ Best Practice Coronavirus disease 2019. 2020. 
 . CC-BY 4.0 International licenseIt is made available under a 
 is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)
The copyright holder for this preprint this version posted May 8, 2020. .https://doi.org/10.1101/2020.05.06.20092734doi: medRxiv preprint 
https://bestpractice.bmj.com/topics/en-gb/3000168/pdf/3000168/Coronavirus 
disease 2019 %28COVID-19%29.pdf. 
17 Sweeney S, Vassall A, Guinness L, et al. Examining Approaches to Estimate the 
Prevalence of Catastrophic Costs Due to Tuberculosis from Small-Scale Studies in 
South Africa. Pharmacoeconomics 2020. DOI:10.1007/s40273-020-00898-3. 
18 World Health Organization. Global Health Expenditure Databse. 2020. 
https://apps.who.int/nha/database (accessed May 4, 2020). 
19 Zandvoort K van, Jarvis CI, Pearson C, et al. Response strategies for COVID-19 
epidemics in African settings: a mathematical modelling study. medRxiv 2020; : 
2020.04.27.20081711. 
20 Lancet T. India under COVID-19 lockdown. Lancet 2020; 395: 1315. 
21 Carding N. Fifth of trust’s medical workforce absent amid covid-19 pandemic | HSJ 
Local | Health Service Journal. Heal. Serv. J. https://www.hsj.co.uk/workforce/fifth-
of-trusts-medical-workforce-absent-amid-covid-19-pandemic/7027329.article 
(accessed May 5, 2020). 
 
 
 . CC-BY 4.0 International licenseIt is made available under a 
 is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)
The copyright holder for this preprint this version posted May 8, 2020. .https://doi.org/10.1101/2020.05.06.20092734doi: medRxiv preprint 
Karachi Delhi Nairobi Addis Ababa Johannesburg
C
as
es
 (
'0
00
s)
0
10
00
20
00
30
00
40
00
50
00
Karachi Delhi Nairobi Addis Ababa Johannesburg
D
ea
th
s 
('0
00
s)
0
5
10
15
20
Karachi Delhi Nairobi Addis Ababa Johannesburg
IC
U
 b
ed
s 
('0
00
s)
0
10
0
20
0
30
0
40
0
Karachi Delhi Nairobi Addis Ababa Johannesburg
N
on
−
IC
U
 b
ed
s 
('0
00
s)
0
50
0
10
00
15
00
20
00
 . CC-BY 4.0 International licenseIt is made available under a 
 is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)
The copyright holder for this preprint this version posted May 8, 2020. .https://doi.org/10.1101/2020.05.06.20092734doi: medRxiv preprint 
Public health Testing Treatment
Income loss
(Mortality) Out−of−pocket
Income loss
(Morbidity)
Karachi
Delhi
Nairobi
Addis Ababa
Johannesburg
C
os
t p
er
 p
er
so
n 
($
)
0
20
40
60
80
10
0
12
0
Health sector Households
 . CC-BY 4.0 International licenseIt is made available under a 
 is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)
The copyright holder for this preprint this version posted May 8, 2020. .https://doi.org/10.1101/2020.05.06.20092734doi: medRxiv preprint 
Time (days)
C
os
t (
$m
)
0
2
4
6
8
0 50 100 150 200 250 300 350
Karachi
Time (days)
C
os
t (
$m
)
0
2
4
6
0 50 100 150 200 250 300 350
Delhi
Time (days)
C
os
t (
$m
)
0.
0
0.
5
1.
0
1.
5
2.
0
2.
5
0 50 100 150 200 250 300 350
Nairobi
Time (days)
C
os
t (
$m
)
0.
0
0.
5
1.
0
1.
5
2.
0
0 50 100 150 200 250 300 350
Addis Ababa
C
os
t (
$m
)
0
2
4
6
8
10
0 50 100 150 200 250 300 350
Johannesburg Public health
Testing
Treatment
Income loss
(Mortality)
Out−of−pocket
Income loss
(Morbidity)
 . CC-BY 4.0 International licenseIt is made available under a 
 is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)
The copyright holder for this preprint this version posted May 8, 2020. .https://doi.org/10.1101/2020.05.06.20092734doi: medRxiv preprint 
Karachi Delhi Nairobi Addis Ababa Johannesburg
N
on
−
IC
U
 b
ed
s:
 p
ea
k 
de
m
an
d
0
20
00
0
60
00
0
10
00
00
150% severity, no surge
100% severity, no surge
50% severity, no surge
150% severity, surge
100% severity, surge
50% severity, surge
capacity
Karachi Delhi Nairobi Addis Ababa Johannesburg
IC
U
 b
ed
s:
 p
ea
k 
de
m
an
d
0
50
00
15
00
0
25
00
0
150% severity, no surge
100% severity, no surge
50% severity, no surge
150% severity, surge
100% severity, surge
50% severity, surge
capacity
Karachi Delhi Nairobi Addis Ababa Johannesburg
H
ea
lth
 c
ar
e 
w
or
ke
rs
 (
da
ys
):
 p
ea
k 
de
m
an
d
0
50
00
00
15
00
00
0
150% severity, no surge
100% severity, no surge
50% severity, no surge
150% severity, surge
100% severity, surge
50% severity, surge
capacity
 . CC-BY 4.0 International licenseIt is made available under a 
 is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)
The copyright holder for this preprint this version posted May 8, 2020. .https://doi.org/10.1101/2020.05.06.20092734doi: medRxiv preprint 
